Inhibition of Histone Lysine-specific Demethylase 1 Elicits Breast Tumor Immunity and Enhances Antitumor Efficacy of Immune Checkpoint Blockade

Immunotherapy strategies have been emerging as powerful weapons against cancer. Early clinical trials reveal that overall response to immunotherapy is low in breast cancer patients, suggesting that effective strategies to overcome resistance to immunotherapy are urgently needed. In this study, we in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene
Hauptverfasser: Qin, Ye, Vasilatos, Shauna N., Chen, Lin, Wu, Hao, Cao, Zhishen, Fu, Yumei, Huang, Min, Vlad, Anda M., Lu, Binfeng, Oesterreich, Steffi, Davidson, Nancy E., Huang, Yi
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6336685/
https://ncbi.nlm.nih.gov/pubmed/30111819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0451-5
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge